trending Market Intelligence /marketintelligence/en/news-insights/trending/ax5ult9blb8mvo525wq7rq2 content esgSubNav
In This List

Motif Bio CFO resigns; interim replacement named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Motif Bio CFO resigns; interim replacement named

New York-based Motif Bio plc said Robert Dickey IV resigned as CFO of the company.

Dickey, who assumed CFO duties January 2017, will continue to serve in an advisory capacity to ensure a smooth transition.

The biopharmaceutical company said it has started the search process for a new CFO, while its nonexecutive director Jonathan Gold has agreed to serve as interim CFO.